Future studies should consider genetic perturbation strategies, such as CRISPR/Cas9‐mediated knockout or RNA interference, combined with lineage tracing, to more precisely delineate the role of BMP2 signaling in MMP11+ mCAF‐mediated tumor progression. The gene discussed is CCL2; the disease is neoplasm.